Multiple endocrine neoplasia.

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia (MEN) is a group of inherited disorders characterized by tumors in two or more endocrine glands.
• Two major forms, MEN1 and MEN2, are recognized, each with distinct clinical manifestations and genetic underpinnings.
• MEN1 involves parathyroid, pancreatic islet, and pituitary tumors, while MEN2 is associated with medullary thyroid carcinoma and phaeochromocytoma.

Purpose of the Study:

• To differentiate the genetic basis and clinical implications of MEN1 and MEN2.
• To highlight the challenges in MEN1 mutational analysis due to diverse mutations and lack of genotype-phenotype correlation.
• To emphasize the more defined genetic landscape of MEN2, facilitating clinical application.

Main Methods:

• Review of genetic mutations associated with MEN1 and MEN2.
• Analysis of genotype-phenotype correlations in MEN1.
• Identification of specific c-ret proto-oncogene mutations in MEN2 variants.

Main Results:

• MEN1 mutations are diverse and scattered across the MEN1 gene on chromosome 11q13, complicating clinical mutational analysis.
• MEN2 is caused by mutations in the c-ret proto-oncogene on chromosome 10cen-10q11.2.
• Specific c-ret mutations correlate with MEN2A, MEN2B, and MTC-only variants, aiding diagnosis and management.

Conclusions:

• MEN1 genetic analysis presents clinical challenges due to mutation heterogeneity.
• MEN2 genetic analysis, focused on c-ret proto-oncogene mutations, is more clinically applicable for diagnosis and family screening.
• Understanding the genetic basis of MEN syndromes is crucial for effective patient management.